ArticleBMJ open2025

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.

Weiyu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.